Advertising in the Journal of Perioperative Echocardiography: A Complete Guide for Pharma and Medical Device Brands Looking to Reach Cardiac Specialists Across India

Most pharmaceutical and medical device companies we speak to have never considered advertising in a perioperative echocardiography journal — and that, frankly, is a significant missed opportunity. The cardiac anesthesiology and echocardiography space in India is growing faster than most people in media planning realise, and the Journal of Perioperative Echocardiography sits at the intersection of a highly specialised, high-prescribing readership that is genuinely difficult to reach through mass media channels. If your product touches cardiac surgery, intraoperative echocardiography, or cardiovascular imaging, the question is not whether you should advertise in JOPE — it is how to do it well.

What Is the Journal of Perioperative Echocardiography (JOPE) and Who Reads It?

The Journal of Perioperative Echocardiography, widely referred to as JOPE, is a peer-reviewed journal published by Jaypee Brothers Medical Publishers — one of India's most respected names in medical publishing — through their Jaypee Journals imprint, with the journal operating under the editorial oversight of specialists in cardiac anesthesia and cardiovascular imaging. The journal is published as a bi-annual journal, meaning two issues per year, which concentrates the readership's engagement with each issue considerably more than monthly publications where attention is spread thin. What a lot of people miss is that a bi-annual publication cadence actually increases the shelf life of every advertisement placed, because each issue is referenced, cited, and circulated among colleagues for a longer period before the next one arrives.

The journal's readership is drawn primarily from cardiac anesthesiologists, intensivists, cardiac surgeons, and echocardiographers — professionals who are directly involved in perioperative cardiac care India-wide, from major tertiary centres like AIIMS cardiac department and Dr. Ram Manohar Lohia Hospital, New Delhi, to private cardiac hospitals in Tier 2 cities. JOPE is indexed on ProQuest, EBSCO, Google Scholar, Genamics Journal Seek, J Gate, HINARI, and PORTICO, which means its articles — and by extension, the advertisements appearing alongside them — are accessed by healthcare professionals not just in India but across South Asia and beyond. The echocardiography readership India-wide for this journal skews heavily toward practising clinicians rather than students, which is precisely the demographic that pharmaceutical and medical device advertising needs to reach.

Jaypee Brothers Medical Publishers, headquartered in Daryaganj, New Delhi, has been a cornerstone of medical publishing India for decades; their Jaypee Journals portfolio spans dozens of specialty titles, and JOPE is among the more focused ones, which is both its limitation in raw circulation numbers and its greatest strength as an advertising vehicle. At SmartAds, we always tell our clients that reach without relevance is just noise — and JOPE offers relevance at a level that general medical journals simply cannot match for brands operating in the perioperative cardiac imaging space.

Why Should Pharma and Medical Device Brands Advertise in JOPE India?

The honest answer is that most brands advertising in cardiac journals are doing so because their sales force cannot be everywhere at once; a well-placed full page advertisement in a peer-reviewed journal like JOPE reinforces the message a medical representative delivers in person, which creates a layered communication effect that is well-documented in pharmaceutical advertising research. The FICCI-EY Media and Entertainment Report has consistently noted that healthcare professional media — including print and digital medical journal advertising — remains one of the most trusted advertising environments for HCP audiences, precisely because the editorial rigour of a peer-reviewed journal lends credibility to the surrounding commercial content by association.

The case for medical journal advertising in a specialised title like JOPE becomes even more compelling when you consider the targeting precision involved. A cardiac anesthesiologist reading the journal is, by definition, someone who performs or supervises transesophageal echocardiography, manages TEE equipment procurement decisions, and influences the purchase of cardiovascular imaging systems, echo-guided catheters, and related pharmacological agents used in perioperative cardiac care. There is no programmatic digital ad format that can replicate this level of intent-based targeting at the specialty level; journal website advertising and email campaign options through the jpecardio.com platform come close, but the print advertisement in the physical journal carries a credibility premium that digital formats are still working to match. We have found, through our work with medical device clients, that the combination of print advertising and digital advertising in the same journal ecosystem produces measurably better recall than either channel used independently.

One automotive brand we worked with — and this is a comparison that sounds unusual until you think about it — once asked us why we were recommending a niche journal over a broader medical magazine for their diagnostic equipment division's campaign. The answer was straightforward: the Society of Transesophageal Echocardiography's membership in India, combined with the Indian Academy of Echocardiography's active community of practitioners, represents a concentrated decision-making audience that is worth far more per impression than a diffuse readership. Targeted advertising in medical publications is not about volume; it is about placing your brand in the exact context where purchase intent is highest.

What Types of Magazine Advertising Are Available in JOPE?

The advertising formats available through the Journal of Perioperative Echocardiography broadly mirror what Jaypee Brothers Medical Publishers offers across their Jaypee Journals portfolio, though the specific advertising specifications and rate card details are best confirmed directly with their New Delhi office or through an authorised media buying partner. From our experience working with medical publishing India clients, the standard print advertising formats include the full page advertisement — which is the most visible and most commonly booked format — the half page advertisement in both horizontal and vertical orientations, the inside cover ad positions (inside front and inside back), and the back cover ad, which commands a premium because it is the first surface a reader encounters when picking up the journal.

Beyond the standard print formats, JOPE also offers options that are often overlooked by first-time advertisers: the inside front cover ad, which is the second-most-premium position after the back cover, and strip advertisements that run along the bottom or side margins of editorial pages. The ad placement strategy matters enormously in a bi-annual journal because there are limited positions per issue, and the most valuable positions — back cover, inside front cover — are often booked months in advance by recurring advertisers who understand the value of consistency. What we tell our clients is that if you are entering a journal advertising programme for the first time, booking a full page advertisement in a standard inside position for two consecutive issues will do more for brand recall than a single back cover ad that appears once and is never followed up.

Digital advertising options through JOPE's online presence include banner advertisement placements on the journal website, which is hosted and managed through the Jaypee Journals digital infrastructure; these banner positions are available in standard IAB sizes and are served to the journal's registered online readership. On top of that, email campaign options tied to the journal's subscriber database allow advertisers to reach verified HCP contacts directly, which is a format that has grown significantly in importance since the pandemic accelerated digital adoption among Indian healthcare professionals. The advertising specifications for digital formats — including pixel dimensions, file size limits, and animation restrictions — are governed by both Jaypee Brothers' internal policies and, for pharmaceutical advertisers, the UCPMP guidelines issued by the Indian pharmaceutical industry's self-regulatory framework.

How Does Print Advertising in JOPE Compare to Digital Options?

Print advertising in a peer-reviewed journal like JOPE carries a contextual authority that is genuinely difficult to quantify but very easy to observe in practice; when a cardiac anesthesiologist sits down with a physical copy of the journal, the reading mode is focused and deliberate, which is the opposite of the distracted scrolling behaviour that characterises most digital content consumption. The CPM for print advertising in a specialised medical journal works out to figures that, on the surface, appear high compared to digital display advertising — but this comparison is misleading, because the audience quality differential between a verified cardiac specialist and a general internet user is not captured in a simple cost-per-thousand calculation. We have seen clients make the mistake of abandoning print advertising for digital purely on CPM grounds, only to find that their brand recall scores among target HCPs dropped significantly in the following quarter.

Digital advertising through the journal website and email campaign formats offers advantages that print cannot match: real-time performance data, the ability to link directly to product information pages, and the flexibility to update creative between placements. Journal website advertising on the jpecardio.com platform, for instance, allows advertisers to track click-through rates and session behaviour in ways that a printed full page advertisement simply cannot provide. The honest assessment, based on our experience at SmartAds, is that the most effective medical journal advertising programmes use print and digital in combination — the print advertisement builds credibility and top-of-mind awareness, while the digital advertising formats drive measurable action and allow for retargeting of engaged readers.

The question of open access journal dynamics is also worth addressing here, because JOPE's content is accessible to a global readership through its indexing on platforms like HINARI and PORTICO, which means digital advertisements placed on the journal website reach an audience that extends well beyond the physical print circulation. A retail client in the medical devices space that we worked with in Pune initially budgeted only for print advertising in two cardiac journals; when we introduced journal website advertising as a complementary layer, their brand recall among surveyed cardiologists in the campaign's target cities improved by a margin that justified the incremental spend several times over. The integrated approach — print advertising anchored by digital advertising support — is, in our view, the correct framework for any serious pharmaceutical advertising or medical device advertising programme in a specialised publication like JOPE.

What Are Sponsored Supplements and How Do They Work in JOPE?

Sponsored supplements are, in our experience, one of the most underutilised formats in pharmaceutical advertising and medical device advertising within Indian medical journals — and that gap represents a real opportunity for brands willing to invest in content-led marketing. A sponsored supplement in the context of JOPE would typically be a separately bound or digitally distributed section of the journal, produced in collaboration with the editorial team, which covers a specific clinical topic relevant to perioperative echocardiography or cardiovascular imaging; the sponsoring brand's name and logo appear prominently, and the supplement is distributed alongside the main journal issue to the full subscriber base. Jaypee Brothers Medical Publishers has a well-established process for managing sponsored supplements across their Jaypee Journals portfolio, and the editorial independence standards that govern the main journal apply equally to supplement content.

The value of a sponsored supplement lies in its ability to provide educational content that positions the sponsoring brand as a thought leader in the perioperative cardiac care space, rather than simply a product advertiser; a supplement on advances in intraoperative echocardiography guidance, for example, would be highly relevant to the cardiac anesthesiologist readership of JOPE and would create a durable association between the sponsoring brand and clinical excellence. Journal sponsorship of this kind is particularly effective when timed to coincide with major conferences — events organised by the Society of Transesophageal Echocardiography or the Indian Academy of Echocardiography, for instance — because the supplement can be distributed both through the journal and as a standalone piece at conference venues, dramatically extending its reach. At SmartAds, we have helped medical device clients develop supplement concepts that were subsequently cited in clinical discussions at national cardiac conferences, which is a level of engagement that no banner advertisement can achieve.

Reprints and e-prints are closely related to the sponsored supplement category and deserve separate attention. A reprint is a professionally produced physical copy of a published article — typically a clinical study or review — which the sponsoring brand can distribute through its medical representative network, at conferences, or by direct mail to targeted HCP lists; an e-print is the digital equivalent, formatted for email distribution or download from a brand's website. Jaypee Brothers Medical Publishers offers reprint and e-print services for articles published in JOPE, and the commercial terms — including minimum order quantities and per-unit costs — are negotiated directly with their publishing team. The strategic value of reprints in pharmaceutical advertising is significant because they allow a brand to associate itself with specific peer-reviewed evidence, which carries far more persuasive weight with a cardiac anesthesiologist than a standard promotional piece.

How to Submit and Book an Advertisement in the Journal of Perioperative Echocardiography?

The booking process for advertising in JOPE follows the standard workflow that Jaypee Brothers Medical Publishers uses across their Jaypee Journals portfolio, which begins with a formal inquiry to their advertising or publishing department — typically routed through their New Delhi headquarters in Daryaganj. The first step is obtaining the current advertising rate card and advertising specifications document, which outlines the available formats, dimensions, file format requirements, and pricing for both print advertising and digital advertising options; this document is not publicly available on the journal's website, which is one of the genuine information gaps that makes working with an experienced media buying partner valuable. We have found that lead times for booking advertisements in a bi-annual journal are considerably longer than advertisers expect — for a journal with two issues per year, the material submission deadline for each issue typically falls six to eight weeks before the publication date, which means planning needs to begin at least three months before the desired issue date.

The advertising specifications for print advertising in JOPE follow standard medical journal requirements: artwork should be submitted as high-resolution PDF or TIFF files, typically at 300 DPI or higher for full page and half page advertisement formats, with dimensions conforming to the journal's trim size. Inside cover ad and back cover ad positions require bleed specifications, which means the artwork must extend beyond the trim edge to account for the printing process; failure to supply bleed-ready artwork is one of the most common reasons for delays in ad placement, and it is something we flag explicitly when briefing creative teams on behalf of our clients. The booking process also requires submission of a formal insertion order, which specifies the issue, position preference, format, and any special instructions — and for pharmaceutical advertising, a compliance declaration confirming that the advertisement has been reviewed against UCPMP guidelines and any applicable regulatory requirements.

An important practical note for brands new to medical journal advertising in India: position preferences are not guaranteed unless they are specifically contracted and confirmed in writing by the publisher. We have seen situations where a client assumed their full page advertisement would run in a premium position because it was requested informally, only to find it placed in a less visible inside location. The lesson is straightforward — always confirm position in writing, understand the publisher's policy on position premiums, and book early enough to have genuine choice in placement. At SmartAds, our role in this process is to handle the rate negotiation, position booking, artwork specification briefing, and compliance review, so that the brand's internal team can focus on the strategic and creative dimensions of the campaign rather than the administrative detail.

What Are the Advertising Policies and Editorial Independence Standards for JOPE?

Advertising editorial independence is a non-negotiable principle for any credible peer-reviewed journal, and JOPE is no exception; the editorial team's decisions about which articles are published, how they are presented, and what clinical conclusions they draw are entirely separate from the commercial advertising relationships managed by Jaypee Brothers Medical Publishers. This separation is not merely a formal policy statement — it is the foundation of the journal's credibility with its readership, and any advertiser who attempts to influence editorial content risks not only rejection but permanent exclusion from the journal's advertising programme. The Society of Transesophageal Echocardiography and the Indian Academy of Echocardiography, as the professional bodies associated with the journal's readership, are particularly attentive to any perceived compromise of editorial integrity.

For pharmaceutical advertising in JOPE, the relevant regulatory framework includes the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) issued by the Indian pharmaceutical industry, which sets standards for the accuracy of claims, the presentation of clinical data, and the disclosure of sponsorship relationships in medical communications. Advertisements for prescription drugs must comply with the Drugs and Magic Remedies (Objectionable Advertisements) Act and the relevant provisions of the Drugs and Cosmetics Act, which restrict the types of claims that can be made in communications directed at healthcare professionals. Medical device advertising is governed by a somewhat different set of regulations, but the principle of accurate, non-misleading claims applies equally; Jaypee Brothers, as the publisher, reserves the right to reject any advertisement that does not meet their standards for accuracy and compliance, regardless of the commercial relationship.

What a lot of people miss is that the advertising policies of a journal like JOPE are actually a feature rather than a limitation from the advertiser's perspective; the fact that the publisher maintains rigorous standards means that the advertising environment is trusted by readers, which in turn means that advertisements appearing in the journal are seen in a favourable context. An advertisement for a transesophageal echocardiography system or a cardiac anesthesia drug that appears in a peer-reviewed journal carries an implicit endorsement from the editorial environment that no paid digital placement can replicate. The practical implication for advertisers is that the investment in producing accurate, well-referenced advertising creative pays dividends not just in compliance terms but in the persuasive impact of the advertisement itself.

Who Is the Target Audience for Advertising in a Perioperative Echocardiography Journal in India?

The readership of the Journal of Perioperative Echocardiography is concentrated among a specific cluster of medical specialties that are directly involved in cardiac surgery and perioperative cardiac care in India: cardiac anesthesiologists, who administer anesthesia and manage hemodynamic monitoring during cardiac procedures; echocardiographers, who perform and interpret TEE and other cardiovascular imaging studies; cardiac surgeons, who rely on intraoperative echocardiography guidance for surgical decision-making; and critical care specialists in cardiac intensive care units, who use echocardiography for post-operative monitoring. This is a readership of perhaps a few thousand active practitioners in India, concentrated in major cardiac centres — institutions like AIIMS cardiac department, large private hospitals in metropolitan cities, and teaching hospitals affiliated with medical universities across the country.

The demographic profile of this readership is worth understanding in detail for advertising planning purposes. The cardiac anesthesiologist and echocardiographer community in India is predominantly based in Tier 1 cities — Mumbai, Delhi, Chennai, Bangalore, Hyderabad, Kolkata — but a significant and growing proportion of practitioners are now working in Tier 2 cities where cardiac surgery programmes have expanded considerably over the past decade. From a pharmaceutical advertising and medical device advertising perspective, this geographic distribution matters because it informs the complementary channels that should be used alongside journal advertising; a campaign that combines JOPE print advertising with targeted digital advertising in Tier 2 city medical communities will reach a broader slice of the relevant HCP population than journal advertising alone. The echocardiography readership India-wide for this journal skews toward senior practitioners — consultants and associate professors rather than residents — which means the audience has genuine prescribing authority and equipment procurement influence.

The connection to professional bodies is also significant for advertisers to understand. Many JOPE readers are members of the Indian Academy of Echocardiography, which publishes its own journal — the Journal of the Indian Academy of Echocardiography and Cardiovascular Imaging (JIAE) — and participates in events organised by the American Society of Echocardiography (ASE) and the Society of Cardiovascular Anesthesiologists (SCA). Advertising in JOPE, therefore, reaches an audience that is actively engaged with the broader global echocardiography community, which is particularly relevant for international medical device and pharmaceutical brands seeking to establish or reinforce their presence in the Indian cardiac imaging publication landscape. At SmartAds, we typically recommend that clients advertising in JOPE also consider conference-tied advertising opportunities linked to Society of Transesophageal Echocardiography events and Indian Academy of Echocardiography annual meetings, because the overlap in audience creates a powerful reinforcement effect.

What Is the ROI of Advertising in a Cardiac Medical Journal in India?

Return on investment in journal advertising is genuinely difficult to measure using the same metrics that digital advertising teams apply to programmatic campaigns, and any agency that tells you otherwise is either oversimplifying or selling you something. What we have found, through our work with pharmaceutical advertising and medical device advertising clients across multiple Indian medical journals, is that the most meaningful ROI metric for this channel is not click-through rate or cost per lead — it is brand recall and prescribing behaviour change among the target HCP audience, measured through post-campaign surveys and sales data analysis. A well-executed campaign in a peer-reviewed journal like JOPE, running across two to four issues with consistent creative and messaging, typically produces measurable improvements in unaided brand recall among the target specialty that justify the investment when compared against the cost of equivalent reach through medical representative visits or conference sponsorships.

To give a concrete sense of the economics involved: one medical device client we worked with, a manufacturer of TEE probes and cardiovascular imaging accessories, ran a four-issue campaign in two cardiac journals simultaneously — one of which was JOPE — combined with conference-tied advertising at a Society of Transesophageal Echocardiography event. The total campaign investment was in the ballpark of what a mid-sized brand would spend on a single national conference sponsorship; the post-campaign measurement showed that unaided brand recall among surveyed cardiac anesthesiologists in the target cities had improved by a margin that the client's internal team described as the best performance they had seen from a print-led campaign in several years. The return on investment journal advertising delivers in this specialty is not about immediate sales conversion — it is about building the kind of consistent, credible presence that influences procurement decisions over a six-to-twelve-month horizon.

The Dentsu e4m Digital Report and various FICCI-EY Media Reports have noted that healthcare professional media spending in India has been growing steadily, with pharmaceutical companies and medical device manufacturers increasingly recognising the value of targeted print and digital advertising in specialty journals alongside their broader digital and field force investments. The GroupM TYNY Report has similarly highlighted that niche professional publications continue to command premium CPMs precisely because their audience quality is unmatched by any mass media alternative. Frankly speaking, the brands that achieve the best return on investment journal advertising in the Indian cardiac imaging publication space are those that treat journal advertising as a sustained programme rather than a one-off insertion; consistency of presence across multiple issues of JOPE, combined with complementary digital advertising and conference activity, is the formula that we have seen work most reliably.

Which Are the Top Competing Echocardiography Journals for Advertising in India?

The most direct competitor to JOPE for advertising budgets targeting the perioperative and cardiac echocardiography audience in India is the Journal of the Indian Academy of Echocardiography and Cardiovascular Imaging (JIAE), which is published by Wolters Kluwer Medknow — one of the most significant names in medical publishing India — and serves as the official publication of the Indian Academy of Echocardiography. JIAE has a broader scope than JOPE, covering all aspects of cardiovascular imaging rather than focusing specifically on perioperative echocardiography, which means its readership is somewhat larger but less concentrated in the cardiac anesthesiology and cardiac surgery specialties that JOPE targets specifically. For a brand whose product is used exclusively in the operating theatre or intensive care setting, JOPE's tighter focus is actually an advantage; for brands with a broader cardiovascular imaging application, JIAE may offer better reach.

The Indian Journal of Thoracic and Cardiovascular Surgery (IJTC), published under the auspices of the Indian Association of Cardiovascular-Thoracic Surgeons (IACTS), is another relevant vehicle for brands advertising in the cardiac surgery and perioperative care space; its readership overlaps with JOPE's among cardiac surgeons and thoracic specialists, though the anesthesiology and echocardiography component of its readership is smaller. International journals — particularly those published by the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists — are also relevant for brands with global advertising programmes, though the Indian readership of these publications is a subset of their global subscriber base rather than a primary audience. The practical implication for media planning is that a brand seeking to dominate the perioperative cardiac care India advertising space should consider JOPE as its primary vehicle, with JIAE and IJTC as complementary placements depending on the specific product and target specialty.

What distinguishes JOPE from its competitors in the context of advertising value is its specific editorial focus on perioperative echocardiography — a subspecialty that sits at the intersection of cardiac anesthesia India, intraoperative echocardiography, and cardiovascular imaging — which makes it the most precisely targeted vehicle available for brands in this space. Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and institutions of similar standing contribute to JOPE's editorial content, which reinforces its credibility among the senior practitioners who are most valuable to advertisers. At SmartAds, our recommendation for clients with limited budgets is to prioritise JOPE for perioperative-specific products and JIAE for broader cardiovascular imaging applications, rather than spreading budget thinly across multiple journals without a clear rationale for each.

Frequently Asked Questions About Advertising in the Journal of Perioperative Echocardiography

Q: How do I place an advertisement in the Journal of Perioperative Echocardiography in India?

The process begins with contacting Jaypee Brothers Medical Publishers through their New Delhi office — their Jaypee Journals advertising team handles all commercial inquiries for JOPE — to request the current advertising rate card and advertising specifications. You will need to specify the issue you are targeting, the format you require (full page advertisement, half page advertisement, inside cover ad, back cover ad, or digital options), and whether you are interested in print advertising, journal website advertising, or a combination. Working through a media buying agency like SmartAds significantly simplifies this process, because we maintain ongoing relationships with the Jaypee Brothers publishing team and can advise on position availability, negotiate rates, and manage the artwork submission process on your behalf. The material submission deadline for each issue of this bi-annual journal typically falls six to eight weeks before publication, so planning should begin at least three months ahead of your desired placement date.

Q: What are the advertising rates and formats available in JOPE?

Jaypee Brothers Medical Publishers does not publish a publicly available advertising rate card for JOPE, which means rates need to be obtained directly from their advertising team or through an authorised media partner. From our experience working with medical publishing India clients, the rates for print advertising in specialised peer-reviewed journals of this type are typically structured around position premiums — the back cover ad and inside front cover ad command the highest rates, followed by the inside back cover, with standard inside full page advertisement positions at the base rate. Half page advertisement formats are priced at roughly half the full page rate, though the exact ratio varies by publisher. Digital advertising options, including banner advertisement placements on the journal website and email campaign formats, are priced separately and are generally more accessible for brands with smaller budgets. We recommend contacting SmartAds.in for a current rate consultation, as we can provide benchmarking against comparable Jaypee Journals and Wolters Kluwer Medknow titles to ensure you are making an informed decision.

Q: Who is the target readership of the Journal of Perioperative Echocardiography?

JOPE's readership is concentrated among cardiac anesthesiologists, echocardiographers, cardiac surgeons, and critical care specialists who are involved in perioperative cardiac care in India and across South Asia. The journal's editorial focus on perioperative echocardiography — including transesophageal echocardiography (TEE), intraoperative echocardiography, and cardiovascular imaging in the surgical setting — means that its readers are practitioners who actively use or supervise the use of echo-guided techniques in operating theatres and cardiac intensive care units. Many readers are affiliated with major cardiac centres, including AIIMS cardiac department and other tertiary institutions, as well as the Indian Academy of Echocardiography and the Society of Transesophageal Echocardiography. The audience skews toward senior practitioners with genuine prescribing and procurement authority, which is the demographic that pharmaceutical advertising and medical device advertising campaigns need to reach most urgently.

Q: Does JOPE offer digital advertising options in addition to print?

Yes, digital advertising options are available through the journal's online infrastructure, managed by Jaypee Brothers Medical Publishers through their Jaypee Journals digital platform. These include banner advertisement placements on the journal website (jpecardio.com), which are served to registered online readers and visitors accessing the journal's open access content; email campaign formats targeted to the journal's verified HCP subscriber database; and digital versions of print advertisements that appear in the journal's online PDF edition. The specifications for digital advertising formats — including dimensions, file formats, and animation policies — are governed by Jaypee Brothers' internal advertising specifications and, for pharmaceutical advertisers, must comply with UCPMP guidelines. We have found that combining print advertising with digital advertising in the same journal ecosystem produces significantly better brand recall outcomes than either format used in isolation.

Q: Can pharmaceutical and medical device companies sponsor a supplement in JOPE?

Sponsored supplements are available through Jaypee Brothers Medical Publishers for JOPE, subject to editorial approval and compliance with the journal's advertising editorial independence policies. A sponsored supplement typically takes the form of a separately bound or digitally distributed section covering a specific clinical topic in perioperative echocardiography or cardiovascular imaging, produced with the involvement of the journal's editorial team to ensure scientific accuracy and independence. The sponsoring brand's name appears prominently, and the supplement is distributed to the full JOPE subscriber base as well as at relevant conferences — events organised by the Society of Transesophageal Echocardiography or the Indian Academy of Echocardiography, for example. Reprints and e-prints of published articles are also available for commercial distribution, allowing brands to associate themselves with specific peer-reviewed evidence in their field. Journal sponsorship of this kind requires early planning — typically six months or more before the intended distribution date — because the editorial development process is substantial.

Q: What is the editorial independence policy for advertisements in Jaypee Journals?

Jaypee Brothers Medical Publishers maintains a strict separation between editorial content and commercial advertising across all titles in their Jaypee Journals portfolio, including JOPE. The editorial team's decisions about article selection, peer review, and publication are entirely independent of the journal's advertising relationships; no advertiser has the right to influence, review, or approve editorial content as a condition of their advertising placement. Advertisements are reviewed by the publisher's team for compliance with accuracy standards, regulatory requirements (including UCPMP guidelines for pharmaceutical advertising), and the journal's general policies on acceptable content. Advertisements that make false or misleading claims, reference unpublished data inappropriately, or violate any applicable regulations will be rejected regardless of the commercial relationship. This editorial independence is, from an advertiser's perspective, a significant asset — it is precisely what makes the journal's readership trust the publication, and by extension, the advertising environment within it.

Q: What types of products and services are accepted for advertising in JOPE?

The Journal of Perioperative Echocardiography accepts advertising for products and services that are relevant to its readership of cardiac anesthesiologists, echocardiographers, and cardiac surgeons. This includes pharmaceutical products used in cardiac anesthesia and perioperative cardiac care, medical devices related to transesophageal echocardiography and cardiovascular imaging (TEE probes, echo machines, imaging software), cardiac monitoring equipment, surgical instruments and accessories used in cardiac surgery, medical education programmes and conferences relevant to the specialty, and professional services of interest to the cardiac anesthesia and echocardiography community. Consumer products, non-medical services, and any advertising that does not meet the journal's relevance and compliance standards are not accepted. For pharmaceutical advertising specifically, all claims must be consistent with the approved prescribing information and compliant with UCPMP guidelines; for medical device advertising, CE marking or Indian regulatory approval documentation may be required.

Q: How does advertising in JOPE compare to advertising in other cardiac journals in India?

The primary distinction is specificity of audience. JOPE is the only Indian peer-reviewed journal dedicated exclusively to perioperative echocardiography, which means its readership is more precisely concentrated in the cardiac anesthesiology and intraoperative echocardiography community than any competing publication. The Journal of the Indian Academy of Echocardiography and Cardiovascular Imaging (JIAE), published by Wolters Kluwer Medknow, has a broader scope and larger circulation, making it a better choice for brands with wider cardiovascular imaging applications; the Indian Journal of Thoracic and Cardiovascular Surgery (IJTC) reaches cardiac surgeons more effectively but has a smaller echocardiography-focused readership. For brands whose products are specifically used in the perioperative setting — TEE systems, cardiac anesthesia drugs, hemodynamic monitoring devices — JOPE offers unmatched targeting precision, even if its absolute circulation numbers are smaller than those of broader journals. Our recommendation at SmartAds is typically to use JOPE as the anchor publication for perioperative-specific campaigns, with JIAE as a complementary vehicle for broader cardiovascular imaging reach.

Q: What is the publication frequency of the Journal of Perioperative Echocardiography?

JOPE is published as a bi-annual journal, meaning two issues per year. This publication frequency is lower than many other medical journals, which typically publish quarterly or monthly, and it has important implications for advertising planning. Each issue of a bi-annual journal has a longer active life in the hands of readers — it is referenced, shared, and consulted over a period of several months rather than being superseded by the next issue within weeks. This extended shelf life means that advertisements in JOPE have a longer active exposure window than equivalent placements in more frequently published journals, which partially offsets the lower absolute frequency of publication. For advertisers, the practical implication is that the booking window for each issue is critical — missing the material submission deadline for one issue means waiting approximately six months for the next opportunity, which makes early planning and advance booking essential.

Q: What databases index the Journal of Perioperative Echocardiography, and how does this affect ad reach?

JOPE is indexed on several major academic and medical databases, including ProQuest, EBSCO, Google Scholar, Genamics Journal Seek, J Gate, HINARI, and PORTICO. This indexing has a significant impact on the effective reach of the journal's content — and, by extension, the digital advertising associated with it — because articles published in JOPE are discoverable by healthcare professionals globally through these platforms, not just by the journal's direct subscribers. For journal website advertising, this means that the audience accessing JOPE content online is broader than the print subscriber base alone; for advertisers considering digital advertising options, the indexed reach of the journal's content is an